Amy Cyr

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Breast 40%
3. Segmental Mastectomy 39%
4. Carcinoma, Intraductal, Noninfiltrating 27%
5. Mastectomy 22%
6. Guidelines 22%
7. Neoplasms 20%
8. Recurrence 17%
9. Sentinel Lymph Node Biopsy 15%
10. Triple Negative Breast Neoplasms 13%
11. Nipples 10%
12. Brachytherapy 9%
13. Sentinel Lymph Node 9%
14. Surgical Oncology 9%
15. Drug Therapy 8%
16. Therapeutics 8%
17. Practice Guidelines 8%
18. Radiotherapy 7%
19. Prophylactic Mastectomy 7%
20. Lymph Nodes 7%
21. Palpation 7%
22. Clinical Trials 7%
23. palbociclib 7%
24. Cyclin-Dependent Kinase 6 6%
25. boldenone undecylenate 6%
26. Randomized Controlled Trials 6%
27. Anastrozole 6%
28. Breast Carcinoma In Situ 6%
29. Cyclin-Dependent Kinase 4 6%
30. Surgeons 6%
31. Shared Decision Making 6%
32. Neoplasm Metastasis 6%
33. Radiation 6%
34. Papilloma 6%
35. Hormones 6%
36. Large-Core Needle Biopsy 5%
37. Quality of Life 5%
38. Breast Diseases 5%
39. Lymph Node Excision 5%
40. Histology 5%
41. Therapeutic Irrigation 5%
42. Community Hospital 5%